Cost Effectiveness and Future of CAR T Therapy – OncLive
|
Cost Effectiveness and Future of CAR T Therapy
OncLive And so, CAR T cells have the most antitumor activity I've ever seen in my career, and it's tremendously gratifying to see going forward. We do need to solve toxicity. We need to figure out how to prevent or head off CRS, and especially we need to work … |
